ExodusPoint Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.46M	Buy	330,390 +237,693	+256%	+$7.06M	0.05%	357
2025 Q4	$2.88M	Buy	92,697 +78,284	+543%	+$2.15M	0.02%	651
2025 Q3	$311K	Buy	+14,413	New	+$260K	﹤0.01%	1297
2025 Q1	–	Sell	-25,724	Closed	-$493K	–	2038
2024 Q4	$493K	Buy	+25,724	New	+$559K	﹤0.01%	1156
2024 Q1	–	Sell	-58,903	Closed	-$1.28M	–	1997
2023 Q4	$1.28M	Sell	58,903 -115,718	-66%	-$1.83M	0.01%	726
2023 Q3	$2.68M	Sell	174,621 -32,590	-16%	-$622K	0.03%	583
2023 Q2	$4.93M	Buy	207,211 +80,310	+63%	+$2.06M	0.04%	453
2023 Q1	$3.23M	Sell	126,901 -63,753	-33%	-$2.04M	0.03%	689
2022 Q4	$5.57M	Buy	190,654 +81,686	+75%	+$1.88M	0.08%	323
2022 Q3	$2.23M	Buy	+108,968	New	+$1.96M	0.03%	755
2022 Q2	–	Sell	-97,745	Closed	-$1.81M	–	2496
2022 Q1	$1.81M	Buy	97,745 +20,988	+27%	+$403K	0.02%	835
2021 Q4	$1.52M	Buy	+76,757	New	+$1.43M	0.02%	874